People with polyendocrine metabolic ovarian syndrome (PMOS) should have their condition diagnosed sooner and be offered an annual review to monitor symptoms, treatment and long-term health risks, according to our draft guideline published for public consultation today.
UK NICE · July 01, 2026
NICE draft guideline on polyendocrine metabolic ovarian syndrome (PMOS): annual review and diagnosis
Original title: New draft PMOS guideline recommends annual review and could mean quicker diagnosis
NICE invites consultation on draft guidance recommending annual review and earlier diagnosis of PMOS to monitor symptoms, treatment and long-term health risks.
Published by UK NICE. HealthSignal links to the original document; the summary above is extracted from the source text.